Month: August 2022

GENEXINE_CI-1

Genexine selected for Late-Breaking Oral Presentation of Phase 2 Study of GX-188E in Combination with KEYTRUDA® (pembrolizumab) in Cervical Cancer at European Society for Medical Oncology (ESMO) Congress 2022

SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700), a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery and development of...

logo-119

Global Veterinary X-Ray Market Report 2022-2027: Rapid Technological Advancements in Animal Healthcare to Drive Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Veterinary X-Ray Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The...